Literature DB >> 8119233

Anabolic actions of parathyroid hormone on bone.

D W Dempster1, F Cosman, M Parisien, V Shen, R Lindsay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8119233     DOI: 10.1210/edrv-14-6-690

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


× No keyword cloud information.
  106 in total

Review 1.  Stemming bone loss by suppressing apoptosis.

Authors:  J M Hock
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone.

Authors:  R L Jilka; R S Weinstein; T Bellido; P Roberson; A M Parfitt; S C Manolagas
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 3.  PTH and PTHrP effects on the skeleton.

Authors:  A C Karaplis; D Goltzman
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 4.  Glucocorticoid-induced osteoporosis.

Authors:  R S Weinstein
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 5.  Update in new anabolic therapies for osteoporosis.

Authors:  Ernesto Canalis
Journal:  J Clin Endocrinol Metab       Date:  2010-04       Impact factor: 5.958

6.  Fasting plasma glucose levels are related to bone mineral density in postmenopausal women with primary hyperparathyroidism.

Authors:  Itoko Hisa; Hiroshi Kaji; Yoshifumi Inoue; Toshitsugu Sugimoto; Kazuo Chihara
Journal:  Int J Clin Exp Med       Date:  2008-09-22

7.  Pulsatile release of parathyroid hormone from an implantable delivery system.

Authors:  Xiaohua Liu; Glenda J Pettway; Laurie K McCauley; Peter X Ma
Journal:  Biomaterials       Date:  2007-06-18       Impact factor: 12.479

8.  Multiple calcium channel transcripts in rat osteosarcoma cells: selective activation of alpha 1D isoform by parathyroid hormone.

Authors:  E L Barry; F A Gesek; S C Froehner; P A Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

Review 9.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

10.  Uninterrupted oral bisphosphonate (pamidronate) therapy of patients with osteoporosis is not associated with chronic stimulation of parathyroid hormone secretion.

Authors:  J O Landman; S E Papapoulos
Journal:  Osteoporos Int       Date:  1995-03       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.